(5S,6R,7R,8S)-5,6,7,8-Tetrahydroxy-2-(2-phenylethyl)-5,6,7,8-tetrahydro-4H-chromen-4-one(CAS: 69809-22-9)

CAS Number
Related Products
2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
CAS Number: 34620-78-5
Ganoderic acid LM2
CAS Number: 508182-41-0
Other Suppliers for (5S,6R,7R,8S)-5,6,7,8-Tetrahydroxy-2-(2-phenylethyl)-5,6,7,8-tetrahydro-4H-chromen-4-one
Basic Information
Molecular Formula
C17H18O6
Molecular Weight
318.33 g/mol
Physical State
Powder
Physical Properties
Density
1.48±0.1 g/cm3 (20 ºC 760 Torr),
Chemical Identifiers
SMILES
c1ccc(cc1)CCc2cc(=O)c3c(o2)[C@H]([C@@H]([C@@H]([C@H]3O)O)O)O
InChIKey
CWMIROLCTHMEEO-JJXSEGSLSA-N
Database References
MDL Number
MFCD30533225
FAQ
The compound (5S,6R,7R,8S)-5,6,7,8-Tetrahydroxy-2-(2-phenylethyl)-5,6,7,8-tetrahydro-4H-chromen-4-one (CAS: 69809-22-9) is subject to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) guidelines, REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) regulations in the EU, and FDA/EPA requirements for chemical safety and environmental protection. Specific regulations may vary based on the intended use and location.
Synthesis alternatives for (5S,6R,7R,8S)-5,6,7,8-Tetrahydroxy-2-(2-phenylethyl)-5,6,7,8-tetrahydro-4H-chromen-4-one (CAS: 69809-22-9) may include using isomers or analogs like (5S,6R,7R,8S)-5,6,7,8-tetrahydroxy-2-(2-phenylethyl)-5,6,7,8-tetrahydro-4H-chromen-4-one derivatives or similar compounds, which offer similar functionalities but with slight structural differences. Common substitute reagents might include phenols, alcohols, or ketones.
The market trend for (5S,6R,7R,8S)-5,6,7,8-Tetrahydroxy-2-(2-phenylethyl)-5,6,7,8-tetrahydro-4H-chromen-4-one (CAS: 69809-22-9) shows a focus on its potential applications in pharmaceuticals and cosmetics due to its bioactive properties. Research trends are increasingly exploring its use in drug discovery and development, particularly in areas like anti-inflammatory and anti-cancer treatments. Market demand is expected to grow with advancements in these fields.
Waste containing (5S,6R,7R,8S)-5,6,7,8-Tetrahydroxy-2-(2-phenylethyl)-5,6,7,8-tetrahydro-4H-chromen-4-one (CAS: 69809-22-9) should be collected and disposed of in accordance with local environmental regulations. Proper waste disposal methods include incineration for hazardous components and professional waste management for non-hazardous waste. Environmental precautions include ensuring containment to prevent spillage and contamination. It is advisable to consult with environmental safety experts for specific disposal guidelines.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures


![4-{(1R,3aS,4R,6aS)-4-[4-(beta-D-Glucopyranosyloxy)-3,5-dimethoxyphenyl]tetrahydro-1H,3H-furo[3,4-c]furan-1-yl}-2,6-dimethoxyphenyl beta-D-glucopyranoside](https://static.chemtradehub.com/structs/667/66791-77-3-74b7.webp)


![2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol](https://static.chemtradehub.com/structs/346/34620-78-5-d616.webp)

![2-(3,4-Dihydroxy-5-methoxyphenyl)-5-(beta-D-glucopyranosyloxy)-7-hydroxy-3-chromeniumyl 6-O-{6-deoxy-4-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-alpha-L-mannopyranosyl}-beta-D-glucopyranoside chloride](https://static.chemtradehub.com/structs/699/69915-09-9-afab.webp)










